Increased Survival of Patients Treated With a Vaccinia Melanoma Oncolysate Vaccine

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1996 • 2,073 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS

1967 • 234 citations

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

1990 • 133 citations

A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma

1995 • 121 citations

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1992 • 89 citations

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma

1987 • 69 citations

A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates

1986 • 65 citations

A new approach in specific, active immunotherapy

1977 • 63 citations

Positive Relationship of Clinical and Serologic Responses to Vaccinia Melanoma Oncolysate

1987 • 55 citations

Immunotherapy of Malignant Melanoma With Vaccinia Virus

1974 • 51 citations

Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma.

1994 • 47 citations

Active specific immunotherapy in malignant melanoma

1989 • 41 citations

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis model

1990 • 30 citations

A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment.

1983 • 28 citations

Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model

1994 • 21 citations

Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial

1996 • 17 citations

Immunotherapy of a Vaccinia Colon Oncolysate Prepared with Interleukin-2 Gene-Encoded Vaccinia Virus and Interferon-α Increases the Survival of Mice Bearing Syngeneic Colon Adenocarcinoma

1994 • 7 citations

Immunotherapy of malignant melanoma with vaccinia virus

1974 • 7 citations